|
|
|
Volumn 23, Issue 4, 1996, Pages 464-474
|
|
Primary chemotherapy in operable breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
FOLINIC ACID;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
METHOTREXATE;
MITOMYCIN;
MITOXANTRONE;
NAVELBINE;
PIRARUBICIN;
TAMOXIFEN;
VINCRISTINE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
HISTOPATHOLOGY;
HUMAN;
LYMPH NODE DISSECTION;
MASTECTOMY;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CONTROLLED CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
FEMALE;
HUMANS;
|
|
EID: 0029819889
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (59)
|
|
References (0)
|
